Cell type-specific plasticity of striatal projection neurons in parkinsonism and L-DOPA-induced dyskinesia.
about
Presynaptic Mechanisms of l-DOPA-Induced Dyskinesia: The Findings, the Debate, and the Therapeutic ImplicationsStriatal Plasticity in L-DOPA- and Graft-Induced Dyskinesia; The Common Link?Multiple Independent Oscillatory Networks in the Degenerating RetinaThe Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic PotentialMorphological changes of glutamatergic synapses in animal models of Parkinson's diseaseLevodopa-induced plasticity: a double-edged sword in Parkinson's disease?Chemogenetic stimulation of striatal projection neurons modulates responses to Parkinson's disease therapy.Loss of Striatonigral GABAergic Presynaptic Inhibition Enables Motor Sensitization in Parkinsonian Mice.Alterations in neuronal activity in basal ganglia-thalamocortical circuits in the parkinsonian state.Zooming in on the small: the plasticity of striatal dendritic spines in L-DOPA-induced dyskinesia.Striatal activation by optogenetics induces dyskinesias in the 6-hydroxydopamine rat model of Parkinson disease.Pathway-Specific Remodeling of Thalamostriatal Synapses in Parkinsonian MiceM4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced DyskinesiaNpas1+ Pallidal Neurons Target Striatal Projection Neurons.Dynamic DNA Methylation Regulates Levodopa-Induced DyskinesiaEarly Impairment of Synaptic and Intrinsic Excitability in Mice Expressing ALS/Dementia-Linked Mutant UBQLN2Splice variants of the CaV1.3 L-type calcium channel regulate dendritic spine morphology.L-DOPA Oppositely Regulates Synaptic Strength and Spine Morphology in D1 and D2 Striatal Projection Neurons in Dyskinesia.Maladaptive Synaptic Plasticity in L-DOPA-Induced DyskinesiaStriatal Neurons Expressing D1 and D2 Receptors are Morphologically Distinct and Differently Affected by Dopamine Denervation in Mice.Corticostriatal synaptic adaptations in Huntington's diseasePharmacology of L-type Calcium Channels: Novel Drugs for Old Targets?Regulation of Postsynaptic Stability by the L-type Calcium Channel CaV1.3 and its Interaction with PDZ ProteinsDysregulation of striatal projection neurons in Parkinson's disease.Loss and remodeling of striatal dendritic spines in Parkinson's disease: from homeostasis to maladaptive plasticity?Hyperkinetic disorders and loss of synaptic downscaling.Basal Ganglia dysfunctions in movement disorders: What can be learned from computational simulations.Striatal D1 medium spiny neuron activation induces dyskinesias in parkinsonian mice.Advances in optogenetic and chemogenetic methods to study brain circuits in non-human primates.Cell-specific α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonism reveals new insights in the development of parkinson's disease.Striatal cholinergic interneurons and Parkinson's disease.Rebuilding a realistic corticostriatal "social network" from dissociated cells.Monoaminergic tone supports conductance correlations and stabilizes activity features in pattern generating neurons of the lobster, Panulirus interruptus.Interneuronal Nitric Oxide Signaling Mediates Post-synaptic Long-Term Depression of Striatal Glutamatergic Synapses.Activity Dynamics and Signal Representation in a Striatal Network Model with Distance-Dependent ConnectivityBalancing the basal ganglia circuitry: a possible new role for dopamine D2 receptors in health and diseaseWAVE1 in neurons expressing the D1 dopamine receptor regulates cellular and behavioral actions of cocainePedunculopontine glutamatergic neurons control spike patterning in substantia nigra dopaminergic neurons.Levodopa treatment and dendritic spine pathology.Striatal synapses, circuits, and Parkinson's disease.
P2860
Q21129423-A849C780-6F9D-451E-B9CD-2056546626ADQ26768220-932C68F5-12E4-4658-A3A8-B4B14D27B566Q26776208-E666B0C8-56AC-4B88-88B8-78E1467C24F7Q26781422-00D6FD95-DBF7-4E68-991A-8FC9AF5A1386Q26781619-8C7CA938-93B0-4B4B-A07D-64E671EE2A89Q27002626-11B1E194-4289-4A6C-9110-2FD1426C2FF6Q30836713-E35FADEE-CA9D-4AE7-BFC8-DBF3729B1E6EQ34492283-F5FFAA47-E6A2-464D-97A7-E283B2B4ED38Q35053448-6B09582D-F2D4-4C3C-AC1D-06DECF7D57B8Q35574934-06498DDD-FEFB-4D2C-AE0F-B98401B7E4C9Q36296271-1A854908-4F12-4FFF-B04F-A06C101AEEF2Q36599026-44F4B57B-C735-4B87-B9C8-251C7E6AA6D4Q36892615-CE2BE1D4-0ECF-41B1-A405-DFC6EE31B1E8Q36914301-7904F820-8732-4386-9133-B8FC2FEA982FQ37241754-8AF66F83-299A-49F1-9950-16F2DE5EBCFBQ37266176-330A9F40-88E0-4473-9773-1057580A7F1CQ37314745-0F4C00A7-9206-4B39-9AC7-A83E9EF831EFQ37344222-28B29385-195E-4549-962D-7AB9605E5DD3Q37516434-EC574B0A-80B8-4101-AEDD-9A0ADB164886Q37609566-18DAD662-631E-43B8-9269-31FDE47F9EBEQ38362877-DBD03537-564F-489A-8C49-1D1707F28B47Q38475657-F15F0E3B-6F1A-4E2B-89EE-5E1B6503E568Q38475692-A772BCF7-397C-4222-B50E-CBE44DEF90B2Q38722989-4983B73D-5AEC-48E8-BE2B-25F4DD5CFB53Q38766091-E137AE26-0AAF-483F-8F39-B46400C8F778Q38847727-73857C23-0E52-4D36-980D-69FB5D689AD9Q38890573-4F801D1C-D33F-40EB-BDA9-423C4A98F38BQ38931640-17AD0FE8-403E-48CB-B790-458FCDD09D96Q39151291-B7C1B7E1-292F-44FE-9872-218C31BF9116Q39377753-B02190DE-28BA-43AE-89A1-705CC77BB14BQ39414543-A76B643A-F53B-4FFC-A2D8-2888BAF6F739Q39791657-C99003BD-8E68-40C7-B166-8796C3C4A8E6Q40353887-C218A99C-B512-46C1-9DDA-D4C6C0CDDA80Q41412530-7B6DDAC4-FB96-496D-810D-901BE19A9F71Q41486511-EB9FAAB6-6E81-4441-97A4-EAEF9C6E4D14Q41878026-4189CDD2-1CA3-4910-8A44-372609621829Q42321747-6154D393-B566-43ED-A911-41264C66ABCFQ42378714-F01AD68B-F4A0-499B-A723-CF9A4B4F3607Q48113066-64CC19C8-7884-4814-B3B0-F47A139B4006Q48138673-5FBDCFDA-124F-4D0D-AAC5-B34F3E84BA64
P2860
Cell type-specific plasticity of striatal projection neurons in parkinsonism and L-DOPA-induced dyskinesia.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Cell type-specific plasticity ...... and L-DOPA-induced dyskinesia.
@ast
Cell type-specific plasticity ...... and L-DOPA-induced dyskinesia.
@en
type
label
Cell type-specific plasticity ...... and L-DOPA-induced dyskinesia.
@ast
Cell type-specific plasticity ...... and L-DOPA-induced dyskinesia.
@en
prefLabel
Cell type-specific plasticity ...... and L-DOPA-induced dyskinesia.
@ast
Cell type-specific plasticity ...... and L-DOPA-induced dyskinesia.
@en
P2093
P2860
P50
P921
P356
P1476
Cell type-specific plasticity ...... and L-DOPA-induced dyskinesia.
@en
P2093
C Savio Chan
D James Surmeier
Luke E Sebel
M Angela Cenci
Myriam Heiman
Steven M Graves
Tim Fieblinger
Tracy S Gertler
P2860
P2888
P356
10.1038/NCOMMS6316
P407
P577
2014-10-31T00:00:00Z
P6179
1048345326